2687-0940Challenges in modern medicine2687-094010.52575/2687-0940-2024-47-3-388-398212SURGERY<strong>Difficulties</strong> <strong>in</strong> <strong>Diagnosing</strong> <strong>Peritoneal</strong> <strong>Mesothelioma&nbsp;</strong>(<strong>Rare</strong> <strong>Clinical</strong> <strong>Case</strong><strong>)</strong><strong>Difficulties</strong> <strong>in</strong> <strong>Diagnosing</strong> <strong>Peritoneal</strong> <strong>Mesothelioma&nbsp;</strong>(<strong>Rare</strong> <strong>Clinical</strong> <strong>Case</strong><strong>)</strong>RomanovMikhail D.RomanovMikhail D.mdromanov@yandex.ruDavydkinVasily I.DavydkinVasily I.KireevaEkaterina M.KireevaEkaterina M.202447300

The goal of the study was to draw the attention of surgeons, angiosurgeons, infectious disease specialists and oncologists to non-standard predictors of peritoneal mesothelioma development and peculiarities of its diagnostics. The artice presents the analysis of publications on the diagnosis of malignant peritoneal mesothelioma and our own clinical observation with unusual disease debut: cervical lymphadenopathy, thrombosis of the branches of the superior vena cava, bilateral exudative pleurisy. Diagnostic algorithm of peritoneal mesothelioma consists of analyzing the results of clinical examination with sequential application of ultrasound, multispiral computed tomography of the neck, thoracic, abdominal and small pelvis organs with intravenous bolus contrast (MSCTAG), positron emission tomography combined with computed tomography (PET/CT). Endovideoscopy with histologic and immunohistochemical examination of peritoneal biopsy specimens using mesothelial lineage antibodies and epithelial markers is the final and clarifying method of diagnostics of malignant peritoneal mesothelioma.

The goal of the study was to draw the attention of surgeons, angiosurgeons, infectious disease specialists and oncologists to non-standard predictors of peritoneal mesothelioma development and peculiarities of its diagnostics. The artice presents the analysis of publications on the diagnosis of malignant peritoneal mesothelioma and our own clinical observation with unusual disease debut: cervical lymphadenopathy, thrombosis of the branches of the superior vena cava, bilateral exudative pleurisy. Diagnostic algorithm of peritoneal mesothelioma consists of analyzing the results of clinical examination with sequential application of ultrasound, multispiral computed tomography of the neck, thoracic, abdominal and small pelvis organs with intravenous bolus contrast (MSCTAG), positron emission tomography combined with computed tomography (PET/CT). Endovideoscopy with histologic and immunohistochemical examination of peritoneal biopsy specimens using mesothelial lineage antibodies and epithelial markers is the final and clarifying method of diagnostics of malignant peritoneal mesothelioma.

peritoneal mesotheliomanon-standard predictors of developmentMSCTAGPET/CTendovideolaparoscopyimmunohistochemistry of peritoneal biopsiesperitoneal mesotheliomanon-standard predictors of developmentMSCTAGPET/CTendovideolaparoscopyimmunohistochemistry of peritoneal biopsies

The work was carried out without external sources of funding.

Список литературыBarbolina T.D., Bagrova S.G. 2023. Sovremennyye podkhody k diagnostike i lecheniyu mezoteliomy [Modern Approaches to the Diagnosis and Treatment of Mesothelioma]. Obzor materialov konferentsii IMIG-2023. Chast&prime; 1: mezotelioma plevry. Zlokachestvennyye opukholi. 13(3s1): 140.Volkov N.M., Barbolina T.D., Borisova T.N., Vladimirova L.Yu., Den&prime;gina N.V., Levchenko E.V. 2023. Prakticheskiye rekomendatsii po lekarstvennomu lecheniyu mezoteliomy plevry, bryushiny i drugikh lokalizatsiy [Practical Recommendations for Drug Treatment of Mesothelioma of the Pleura, Peritoneum and Other Localizations]. Prakticheskiye rekomendatsii RUSSCO, chast&prime; 1. Zlokachestvennyye opukholi. 13(3s2): 72&ndash;88. doi: 10.18027/2224-5057-2023-13-3s2-1-72-88Kaprin A.D., Starinskiy V.V., Shakhzadova A.O. 2022. Sostoyaniye onkologicheskoy pomoshchi naseleniyu Rossii v 2022 godu [The State of Cancer Care for the Population of Russia in 2022]. M., MNIOI im. P.A. Gertsena &minus; filial FGBU &laquo;NMITS radiologii&raquo; Minzdrava Rossii: 239.Koval&prime; T.I., Izyumskaya E.M., Marchenko E.G., Priymenko N.O., Kotelevskaya T.M., Bodnar V.A. 2021. Limfadenopatiya: algoritm diagnostiki i taktika vedeniya patsiyenta [Lymphadenopathy: Diagnostic Algorithm and Patient Management Tactics]. Klinicheskaya infektologiya i parazitologiya. 10(2): 187&ndash;199. doi: 10.34883/PI.2021.10.2.025.Tarakanova O.V., Slavnova E.N., Tyusheva V.V., Bol&prime;shakova D.A. 2023. Morfologicheskaya diagnostika mezoteliomy. Klinicheskiy sluchay [Morphological Diagnosis of Mesothelioma. Clinical case]. Novosti klinicheskoy tsitologii Rossii. 27(1): 15&ndash;19. doi: 10.24412/1562-4943-2023-1-0003Alhamadh M.S., Alanazi R.B., Wadaan O.M., Alhabeeb A.Y., Alkaiyat M., Aljarbou O.Z., Sabatin F. 2023. Thrombocytosis as a Paraneoplastic Syndrome in Metastatic Malignant Peritoneal Mesothelioma of Biphasic Morphology Mimicking Ovarian Adenocarcinoma: A Case Report. Clin. Case Rep. Mar 2, 11(3): e6974. doi: 10.1002/ccr3.6974Ali M., Elhatw A., Hegazy M., Albeyoumi H., Sakr N., Deyab A.M., Soliman A.Y., Said E., Samir Elbehwashy A., Nassar M., Alfishawy M. 2022. The Evaluation of Lymphadenopathy in a Resource-Limited Setting. Cureus. 14(10): e30623. doi: 10.7759/cureus.30623Carlson B., Harmath C., Turaga K., Kindler H.L., Armato S.G. 3rd, Straus C. 2022. The Role of Imaging in Diagnosis and Management of Malignant Peritoneal Mesothelioma: A Systematic Review. Abdom. Radiol. (NY). 47(5): 1725&ndash;1740. doi: 10.1007/s00261-022-03464-xChun C.P., Song L.X., Zhang H.P., Guo D.D., Xu G.X., Li Y., Xin X., Cao J., Li F. 2023. Malignant Peritoneal Mesothelioma. Am. J. Med. Sci. 365(1): 99&ndash;103. doi: 10.1016/j.amjms.2022.07.008Hiltbrunner S., Fleischmann Z., Sokol E., Zoche M., Felley-Bosco E. 2022. Genomic Landscape of Pleural and Peritoneal Mesothelioma Tumours. Br. J. Cancer. 127(11): 1997&ndash;2005Huang X., Hong Y., Xie S.Y., Liao H.L., Huang H.M., Liu J.H., Long W.J. 2022. Malignant Peritoneal Mesothelioma with Massive Ascites as the First Symptom: A Case Report. World J. Clin. Cases. 10(28): 10317&ndash;10325. doi: 10.12998/wjcc.v10.i28.10317Kuribayashi K., Kitajima K., Minami T., Ikeda M., Yamakado K., Kijima T. 2022. Malignant Peritoneal Mesothelioma Features Shown by FDG-PET/CT. Cancer Diagn. Progn. 2(6): 654&ndash;660. doi: 10.21873/cdp.10156Kusamura S., Baratti D., De Simone M., Pasqual E.M., Ansaloni L., Marrelli D., Robella M., Accarpio F., Valle M., Scaringi S., Biacchi D., Palopoli C., Gazzanelli S., Guaglio M., Deraco M. 2023. Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma. Cancers (Basel). 15(3): 662. doi: 10.3390/cancers15030662Leci-Tahiri L., Zherka-Saracini H., Tahiri A., Koshi A. 2018. Bilateral Internal Jugular Vein Thrombosis Due to Malignant Tumor. Med. Case Reports. 12(1): 42. doi: 10.1186/s13256-017-1556-0Liang X.L., Su Y.D., Li X.B., Fu Y.B., Ma R., Yang R., Wu H.L., Li Y. 2024. Risk Factors and Prognosis of Malignant Peritoneal Mesothelioma with Paraneoplastic Syndrome. World J. Surg. Oncol. 22(1): 29. doi: 10.1186/s12957-024-03312-wRao N., Wei S. 2022. Mesothelioma. Cytojournal. 19(10). doi: 10.25259/cmas_02_08_2021.Sousa B., Silva J., Monteiro N., Romano M., Ara&uacute;jo E. 2023. Malignant Peritoneal Mesothelioma: A Case Report. Cureus. 15(8): e42902. doi: 10.7759/cureus.42902Subahi E.A., Fadul A., Mohamed A., Alsayed A., Ali E.A., Sayed S., Mustafa S., Wazwaz B., Fadul M.H. 2024. Biphasic Peritoneal Mesothelioma Is a Rare Tumor and a Diagnostic Challenge: A Case Report. Cureus. 16(1): e51725. doi: 10.7759/cureus.51725Sugarbaker P.H., Chang D., Jelinek J.S. 2021. Concerning CT Features Predict Outcome of Treatment in Patients with Malignant Peritoneal Mesothelioma. Eur. J. Surg. Oncol. 47(9): 2212&ndash;2219. doi: 10.1016/j.ejso.2021.04.012Sun L.,&nbsp;Li Ch.,&nbsp;Gao Sh. 2023. Diffuse Malignant Peritoneal Mesothelioma: A Review. Front.&nbsp;Surg. 6(9): 1015884. doi: 10.3389/fsurg.2022.1015884Tandon R.T., Jimenez-Cortez Y., Taub R., Borczuk A.C. 2018. Immunohistochemistry in Peritoneal Mesothelioma: A Single-Center Experience of 244 Cases. Arch. Pathol. Lab. Med. 142(2): 236&ndash;242. doi: 10.5858/arpa.2017-0092-OAUllah A., Waheed A., Khan J., Mishra A., Tareen B., Nama N., Karki N.R., Panezai M.S., Zarate L.V., White J., Cason F.D., Matolo N., Misra S., Karim N.A. 2022. Incidence, Survival Analysis and Future Perspective of Primary Peritoneal Mesothelioma (PPM): A Population-Based Study from SEER Database. Cancers (Basel). 14(4): 942. doi: 10.3390/cancers14040942Verma R., Khera S. 2020. Cervical Lymphadenopathy: A Review. Int. J. Health Sci. Res. 10(10): 292&ndash;298.Verma V., Sleightholm R.L., Rusthoven C.G., Koshy M., Sher D.J., Grover S., Simone C.B. (2018). Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival.&nbsp;Annals of Surgical Oncology.&nbsp;25(7): 2018&ndash;2026.&nbsp;doi: 10.1245/s10434-018-6499-1Zannella S., Testi M.A., Cattoretti G., Pelosi G., Zucchini N. 2014. Peritoneal Malignant Mesothelioma Metastatic to Supraclavicular Lymph Nodes. Int. J. Surg. Pathol. 22(6): 552&ndash;554. doi: 10.1177/1066896913520037Zeng X., Xu K., Zhang L., Huang X. 2022. Challenging Diagnostic Process for a Malignant Peritoneal Mesothelioma Patient with Ascites and Pleural Effusion: A Case Report and Review of the Literature. Front. Oncol. 15(12): 784064. doi: 10.3389/fonc.2022.784064